您当前的位置:
首页 >
文章列表页 >
ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression
ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression
ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression
- “在前列腺癌症治疗领域,研究人员已确定ADP-依赖性葡萄糖激酶(ADPGK)为关键靶点。研究发现,ADPGK的高表达与前列腺癌症患者的不良生存结果有关。ADPGK通过激活ALDOC-AMPK信号通路,加速癌症糖酵解和进展,为构建新的癌症治疗和预后评估系统奠定基础。”
- MMR 2024年11卷第5期 页码:643-662
DOI: 10.1186/s40779-023-00500-9
移动端阅览
AI导读
HTML全文
图( 8 ) 表( 1 )
参考文献
出版信息
数据统计
78
浏览量
24
下载量
1
CSCD
文章被引用时,请邮件提醒。
提交
工具集
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
相关文章
Emerging roles of ADP-dependent glucokinase in prostate cancer
ADP-dependent glucokinase: the ancient, archaeal key to prostate cancer
Intelligent medicine in focus: the 5 stages of evolution in robot-assisted surgery for prostate cancer in the past 20 years and future implications
Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients
Frostbite: diagnosis, treatment, prognosis, and future directions
相关作者
Xu Zhang
Marcin M. Kamiński
Bai-Rong Shen
Qiang Wei
Lu Yang
Jia-Ming Zheng
Qi Deng
Qi-Yu Zhu
相关机构
Department of Urology, the Third Medical Centre, Chinese PLA General Hospital
Department of Immunology, St. Jude Children’s Research Hospital
Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University
Department of Computer Science and Information Technologies, Elviña Campus, University of A Coruña
Chinese Academy of Medical Science Oxford Institute, Nuffield Department of Medicine, University of Oxford

